Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

Publisher Website
Google Scholar
Abstract
The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15–45 years. After 4 weeks of treatment, pain, as measured using the Brief Pain Inventory, was decreased compared with baseline. Treatment was generally well tolerated. This study indicates that gabapentin should be considered as a treatment option for the neuropathic pain of Fabry disease.

This publication has 3 references indexed in Scilit: